Comex 信息 韩国 30 - pharmaceutical products 3002 - 人体或动物制品
圖形 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/WD-KR/1064/1/1/Fob/DepartureCountry-Date/All-South-Korea-Imports-1064-Year.png)
圖形 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/WD-KR/1064/1/1/Fob/DepartureCountry-Date/All-South-Korea-Imports-1064-Year.png)
表 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Export Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 美國 | 739.111.000 | 1.256.754.000 | 947.967.000 | 834.158.000 | 887.881.000 | 708.230.000 |
| 比利時 | 99.460.000 | 1.405.992.000 | 1.158.228.000 | 412.797.000 | 264.706.000 | 214.595.000 |
| 德國 | 327.312.000 | 718.709.000 | 511.181.000 | 439.970.000 | 457.604.000 | 440.387.000 |
| 土耳其 | 617.189.000 | 350.886.000 | 434.884.000 | 484.953.000 | 322.640.000 | 394.367.000 |
| 愛爾蘭 | 215.714.000 | 200.930.000 | 292.339.000 | 434.383.000 | 371.703.000 | 296.078.000 |
| 瑞士 | 283.552.000 | 381.159.000 | 259.986.000 | 257.229.000 | 255.032.000 | 264.495.000 |
| 新加坡 | 208.413.000 | 122.238.000 | 238.059.000 | 175.975.000 | 217.085.000 | 224.454.000 |
| 日本 | 110.970.000 | 150.354.000 | 163.490.000 | 217.506.000 | 150.080.000 | 149.308.000 |
| 法國 | 53.382.000 | 65.747.000 | 57.141.000 | 83.071.000 | 160.978.000 | 150.997.000 |
| 丹麥 | 69.463.000 | 28.056.000 | 52.593.000 | 81.947.000 | 169.799.000 | 133.490.000 |
| Others | 304.190.000 | 369.408.000 | 474.725.000 | 563.626.000 | 588.997.000 | 521.738.000 |
| Total | 3,028,756,000 | 5,050,233,000 | 4,590,593,000 | 3,985,615,000 | 3,846,505,000 | 3,498,139,000 |
圖形 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/WD-KR/1064/1/4/Fob/DepartureCountry-Date/All-South-Korea-Imports-1064-Month.png)
圖形 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/WD-KR/1064/1/4/Fob/DepartureCountry-Date/All-South-Korea-Imports-1064-Month.png)
表 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Export Countries
|
06 - 2025 | 07 - 2025 | 08 - 2025 | 09 - 2025 | 10 - 2025 | 11 - 2025 |
|---|---|---|---|---|---|---|
| 美國 | 61.569.000 | 60.358.000 | 78.165.000 | 58.532.000 | 46.960.000 | 51.778.000 |
| 德國 | 45.426.000 | 57.835.000 | 35.309.000 | 43.245.000 | 39.127.000 | 27.121.000 |
| 土耳其 | 14.253.000 | 41.852.000 | 2.714.000 | 41.603.000 | 60.202.000 | 66.002.000 |
| 比利時 | 12.862.000 | 25.135.000 | 14.507.000 | 129.399.000 | 972.000 | 3.357.000 |
| 新加坡 | 24.386.000 | 32.958.000 | 9.319.000 | 16.679.000 | 40.381.000 | 22.806.000 |
| 瑞士 | 25.936.000 | 28.967.000 | 11.058.000 | 30.573.000 | 24.255.000 | 19.162.000 |
| 法國 | 15.631.000 | 36.331.000 | 17.948.000 | 14.467.000 | 17.094.000 | 18.891.000 |
| 愛爾蘭 | 10.729.000 | 21.501.000 | 21.810.000 | 20.255.000 | 19.162.000 | 21.770.000 |
| 日本 | 10.206.000 | 12.952.000 | 19.851.000 | 17.601.000 | 13.629.000 | 16.830.000 |
| 義大利 | 8.283.000 | 10.786.000 | 6.708.000 | 4.254.000 | 10.125.000 | 25.024.000 |
| Others | 61.190.000 | 80.311.000 | 33.427.000 | 53.215.000 | 38.184.000 | 63.693.000 |
| Total | 290,471,000 | 408,986,000 | 250,816,000 | 429,823,000 | 310,091,000 | 336,434,000 |
圖形 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/KR-WD/1064/2/1/Fob/DestinationCountry-Date/South-Korea-All-Exports-1064-Year.png)
圖形 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/KR-WD/1064/2/1/Fob/DestinationCountry-Date/South-Korea-All-Exports-1064-Year.png)
表 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Import Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 美國 | 554.699.000 | 1.063.757.000 | 802.525.000 | 844.958.000 | 1.303.500.000 | 1.595.154.000 |
| 德國 | 1.840.096.000 | 1.745.830.000 | 621.836.000 | 480.282.000 | 527.806.000 | 701.265.000 |
| 匈牙利 | 213.567.000 | 232.300.000 | 174.924.000 | 313.707.000 | 1.268.320.000 | 878.420.000 |
| 土耳其 | 583.676.000 | 353.043.000 | 516.054.000 | 363.155.000 | 415.703.000 | 366.193.000 |
| 瑞士 | 188.633.000 | 161.152.000 | 220.660.000 | 272.725.000 | 438.402.000 | 1.042.131.000 |
| 荷蘭 | 330.107.000 | 257.712.000 | 92.739.000 | 207.195.000 | 202.521.000 | 595.072.000 |
| 日本 | 149.670.000 | 312.693.000 | 271.933.000 | 375.166.000 | 204.329.000 | 231.578.000 |
| 比利時 | 277.120.000 | 227.175.000 | 167.052.000 | 312.386.000 | 397.268.000 | 161.732.000 |
| 義大利 | 60.348.000 | 186.857.000 | 325.408.000 | 268.636.000 | 324.491.000 | 226.332.000 |
| 巴西 | 165.090.000 | 146.044.000 | 186.127.000 | 156.277.000 | 197.254.000 | 153.109.000 |
| Others | 1.423.140.000 | 2.478.465.000 | 1.861.360.000 | 1.308.537.000 | 1.263.145.000 | 1.253.738.000 |
| Total | 5,786,146,000 | 7,165,028,000 | 5,240,618,000 | 4,903,024,000 | 6,542,739,000 | 7,204,724,000 |
圖形 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/KR-WD/1064/2/4/Fob/DestinationCountry-Date/South-Korea-All-Exports-1064-Month.png)
圖形 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/KR-WD/1064/2/4/Fob/DestinationCountry-Date/South-Korea-All-Exports-1064-Month.png)
表 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Import Countries
|
06 - 2025 | 07 - 2025 | 08 - 2025 | 09 - 2025 | 10 - 2025 | 11 - 2025 |
|---|---|---|---|---|---|---|
| 美國 | 453.169.000 | 132.108.000 | 92.385.000 | 95.770.000 | 120.892.000 | 67.891.000 |
| 瑞士 | 84.461.000 | 19.859.000 | 160.403.000 | 149.255.000 | 75.575.000 | 173.352.000 |
| 匈牙利 | 90.714.000 | 92.311.000 | 31.961.000 | 77.821.000 | 78.487.000 | 78.913.000 |
| 荷蘭 | 42.378.000 | 40.503.000 | 18.170.000 | 128.488.000 | 15.872.000 | 138.316.000 |
| 日本 | 31.391.000 | 10.754.000 | 18.373.000 | 49.338.000 | 36.397.000 | 44.607.000 |
| 土耳其 | 11.129.000 | 22.389.000 | 33.834.000 | 63.571.000 | 40.499.000 | 11.622.000 |
| 義大利 | 4.979.000 | 16.653.000 | 19.876.000 | 48.455.000 | 17.408.000 | 20.738.000 |
| 比利時 | 2.855.000 | 3.437.000 | 5.204.000 | 24.763.000 | 32.981.000 | 35.332.000 |
| 德國 | 11.016.000 | 17.534.000 | 29.968.000 | 13.110.000 | 4.083.000 | 13.928.000 |
| 巴西 | 11.473.000 | 10.881.000 | 15.397.000 | 14.893.000 | 17.055.000 | 17.214.000 |
| Others | 107.823.000 | 97.371.000 | 127.268.000 | 120.319.000 | 110.561.000 | 134.088.000 |
| Total | 851,388,000 | 463,800,000 | 552,839,000 | 785,783,000 | 549,810,000 | 736,001,000 |
圖形 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/KR-KR/1064/3/1/Fob/-/South-Korea-Import-Export-1064-Year.png)
圖形 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/KR-KR/1064/3/1/Fob/-/South-Korea-Import-Export-1064-Year.png)
表 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Export Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Importaciones | ||||||
| 美國 | 739.111.000 | 1.256.754.000 | 947.967.000 | 834.158.000 | 887.881.000 | 708.230.000 |
| 比利時 | 99.460.000 | 1.405.992.000 | 1.158.228.000 | 412.797.000 | 264.706.000 | 214.595.000 |
| 德國 | 327.312.000 | 718.709.000 | 511.181.000 | 439.970.000 | 457.604.000 | 440.387.000 |
| 土耳其 | 617.189.000 | 350.886.000 | 434.884.000 | 484.953.000 | 322.640.000 | 394.367.000 |
| 愛爾蘭 | 215.714.000 | 200.930.000 | 292.339.000 | 434.383.000 | 371.703.000 | 296.078.000 |
| 瑞士 | 283.552.000 | 381.159.000 | 259.986.000 | 257.229.000 | 255.032.000 | 264.495.000 |
| 新加坡 | 208.413.000 | 122.238.000 | 238.059.000 | 175.975.000 | 217.085.000 | 224.454.000 |
| 日本 | 110.970.000 | 150.354.000 | 163.490.000 | 217.506.000 | 150.080.000 | 149.308.000 |
| 法國 | 53.382.000 | 65.747.000 | 57.141.000 | 83.071.000 | 160.978.000 | 150.997.000 |
| 丹麥 | 69.463.000 | 28.056.000 | 52.593.000 | 81.947.000 | 169.799.000 | 133.490.000 |
| Others | 304.190.000 | 369.408.000 | 474.725.000 | 563.626.000 | 588.997.000 | 521.738.000 |
| Total | 3,028,756,000 | 5,050,233,000 | 4,590,593,000 | 3,985,615,000 | 3,846,505,000 | 3,498,139,000 |
|
Date
Import Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Exportaciones | ||||||
| 美國 | 554.699.000 | 1.063.757.000 | 802.525.000 | 844.958.000 | 1.303.500.000 | 1.595.154.000 |
| 德國 | 1.840.096.000 | 1.745.830.000 | 621.836.000 | 480.282.000 | 527.806.000 | 701.265.000 |
| 匈牙利 | 213.567.000 | 232.300.000 | 174.924.000 | 313.707.000 | 1.268.320.000 | 878.420.000 |
| 土耳其 | 583.676.000 | 353.043.000 | 516.054.000 | 363.155.000 | 415.703.000 | 366.193.000 |
| 瑞士 | 188.633.000 | 161.152.000 | 220.660.000 | 272.725.000 | 438.402.000 | 1.042.131.000 |
| 荷蘭 | 330.107.000 | 257.712.000 | 92.739.000 | 207.195.000 | 202.521.000 | 595.072.000 |
| 日本 | 149.670.000 | 312.693.000 | 271.933.000 | 375.166.000 | 204.329.000 | 231.578.000 |
| 比利時 | 277.120.000 | 227.175.000 | 167.052.000 | 312.386.000 | 397.268.000 | 161.732.000 |
| 義大利 | 60.348.000 | 186.857.000 | 325.408.000 | 268.636.000 | 324.491.000 | 226.332.000 |
| 巴西 | 165.090.000 | 146.044.000 | 186.127.000 | 156.277.000 | 197.254.000 | 153.109.000 |
| Others | 1.423.140.000 | 2.478.465.000 | 1.861.360.000 | 1.308.537.000 | 1.263.145.000 | 1.253.738.000 |
| Total | 5,786,146,000 | 7,165,028,000 | 5,240,618,000 | 4,903,024,000 | 6,542,739,000 | 7,204,724,000 |
圖形 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/KR-KR/1064/3/4/Fob/-/South-Korea-Import-Export-1064-Month.png)
圖形 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/KR-KR/1064/3/4/Fob/-/South-Korea-Import-Export-1064-Month.png)
表 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Export Countries
|
06 - 2025 | 07 - 2025 | 08 - 2025 | 09 - 2025 | 10 - 2025 | 11 - 2025 |
|---|---|---|---|---|---|---|
| Importaciones | ||||||
| 美國 | 61.569.000 | 60.358.000 | 78.165.000 | 58.532.000 | 46.960.000 | 51.778.000 |
| 德國 | 45.426.000 | 57.835.000 | 35.309.000 | 43.245.000 | 39.127.000 | 27.121.000 |
| 土耳其 | 14.253.000 | 41.852.000 | 2.714.000 | 41.603.000 | 60.202.000 | 66.002.000 |
| 比利時 | 12.862.000 | 25.135.000 | 14.507.000 | 129.399.000 | 972.000 | 3.357.000 |
| 新加坡 | 24.386.000 | 32.958.000 | 9.319.000 | 16.679.000 | 40.381.000 | 22.806.000 |
| 瑞士 | 25.936.000 | 28.967.000 | 11.058.000 | 30.573.000 | 24.255.000 | 19.162.000 |
| 法國 | 15.631.000 | 36.331.000 | 17.948.000 | 14.467.000 | 17.094.000 | 18.891.000 |
| 愛爾蘭 | 10.729.000 | 21.501.000 | 21.810.000 | 20.255.000 | 19.162.000 | 21.770.000 |
| 日本 | 10.206.000 | 12.952.000 | 19.851.000 | 17.601.000 | 13.629.000 | 16.830.000 |
| 義大利 | 8.283.000 | 10.786.000 | 6.708.000 | 4.254.000 | 10.125.000 | 25.024.000 |
| Others | 61.190.000 | 80.311.000 | 33.427.000 | 53.215.000 | 38.184.000 | 63.693.000 |
| Total | 290,471,000 | 408,986,000 | 250,816,000 | 429,823,000 | 310,091,000 | 336,434,000 |
|
Date
Import Countries
|
06 - 2025 | 07 - 2025 | 08 - 2025 | 09 - 2025 | 10 - 2025 | 11 - 2025 |
|---|---|---|---|---|---|---|
| Exportaciones | ||||||
| 美國 | 453.169.000 | 132.108.000 | 92.385.000 | 95.770.000 | 120.892.000 | 67.891.000 |
| 瑞士 | 84.461.000 | 19.859.000 | 160.403.000 | 149.255.000 | 75.575.000 | 173.352.000 |
| 匈牙利 | 90.714.000 | 92.311.000 | 31.961.000 | 77.821.000 | 78.487.000 | 78.913.000 |
| 荷蘭 | 42.378.000 | 40.503.000 | 18.170.000 | 128.488.000 | 15.872.000 | 138.316.000 |
| 日本 | 31.391.000 | 10.754.000 | 18.373.000 | 49.338.000 | 36.397.000 | 44.607.000 |
| 土耳其 | 11.129.000 | 22.389.000 | 33.834.000 | 63.571.000 | 40.499.000 | 11.622.000 |
| 義大利 | 4.979.000 | 16.653.000 | 19.876.000 | 48.455.000 | 17.408.000 | 20.738.000 |
| 比利時 | 2.855.000 | 3.437.000 | 5.204.000 | 24.763.000 | 32.981.000 | 35.332.000 |
| 德國 | 11.016.000 | 17.534.000 | 29.968.000 | 13.110.000 | 4.083.000 | 13.928.000 |
| 巴西 | 11.473.000 | 10.881.000 | 15.397.000 | 14.893.000 | 17.055.000 | 17.214.000 |
| Others | 107.823.000 | 97.371.000 | 127.268.000 | 120.319.000 | 110.561.000 | 134.088.000 |
| Total | 851,388,000 | 463,800,000 | 552,839,000 | 785,783,000 | 549,810,000 | 736,001,000 |
